MedTrace Logo

Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus

NCT01600365 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2012-05-17

No results posted yet for this study

Summary

The purpose of this study is to study the use of ganciclovir gel 0.3% for treatment of conjunctivitis caused by adenovirus.

Conditions

Interventions

DRUG

Ophthalmic gel (placebo)

Ophthalmic gel (placebo): applied in affected eye 4 times daily for 10 days

DRUG

Ganciclovir

Ophthalmic gel ganciclovir 0,3%: applied in affected eye 4 times daily for 10 days

Sponsors & Collaborators

  • Adapt Produtos Oftalmológicos Ltda.

    lead INDUSTRY

Principal Investigators

  • Rubens Belfort, PhD, MD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-06-30
Completion
2012-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01600365 on ClinicalTrials.gov